OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that applications are now open for its Innovators in Science Award.This prestigious global award ...

Takeda Investor Conference Call and Webcast Details. Takeda will host an investor call regarding this update on Sunday, June 1, 6-6:45 pm CDT/ 7-7:45 pm EDT / Monday, June 2, ...

Zodiacs & Astrology News: In a quirky fusion of astrology and sports, the stars align with the characters of 'Haikyu!!', matching zodiac signs to volleyball players. From Aries ...

NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass., June 01, 2025--Protagonist Therapeutics, Inc. ("Protagonist") (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announced detailed results from the ...

Internal documents revealed Takeda and Lilly knew about the bladder cancer risk as early as 1999. After the FDA mandated a bladder cancer warning for Actos in 2011, drug sales dropped by 80% ...

ERIN, Wisconsin (Kyodo) -- Japanese golfer Rio Takeda grabbed a share of the lead with a 4-under 68 in the first round of the U.S. Women's Open at Eri ...

Takeda has received approval from the European Commission (EC) for its Pfizer-partnered blood cancer drug Adcetris (brentuximab vedotin). The drug has been approved in combination with the ...

At ASCO Day 3, AstraZeneca dominates, Takeda reveals experimental drug data, Eli Lilly serves salad. The SERD spectacle, the VERIFY study, and the dream of a better multi-cancer liquid biopsy test.

Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC Immune’s amyloid-targeting immunotherapy.

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, snaring an $882 million partnership with Takeda for up to five rare disease programmes. The alliance ...

View today's Takeda Pharmaceutical Co., Ltd. stock price and latest 4502 news and analysis. Create real-time notifications to follow any changes in the live stock price.